321 related articles for article (PubMed ID: 11344042)
1. A review of the genotoxicity of marketed pharmaceuticals.
Snyder RD; Green JW
Mutat Res; 2001 May; 488(2):151-69. PubMed ID: 11344042
[TBL] [Abstract][Full Text] [Related]
2. An update on the genotoxicity and carcinogenicity of marketed pharmaceuticals with reference to in silico predictivity.
Snyder RD
Environ Mol Mutagen; 2009 Jul; 50(6):435-50. PubMed ID: 19334052
[TBL] [Abstract][Full Text] [Related]
3. Genotoxicity and carcinogenicity studies of antihypertensive agents.
Brambilla G; Martelli A
Mutat Res; 2006 Mar; 612(2):115-49. PubMed ID: 16458045
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity and carcinogenicity studies of bronchodilators and antiasthma drugs.
Brambilla G; Mattioli F; Robbiano L; Martelli A
Basic Clin Pharmacol Toxicol; 2013 May; 112(5):302-13. PubMed ID: 23374861
[TBL] [Abstract][Full Text] [Related]
5. Genotoxic and carcinogenic effects of gastrointestinal drugs.
Brambilla G; Mattioli F; Martelli A
Mutagenesis; 2010 Jul; 25(4):315-26. PubMed ID: 20478972
[TBL] [Abstract][Full Text] [Related]
6. Genotoxicity and carcinogenicity studies of analgesics, anti-inflammatory drugs and antipyretics.
Brambilla G; Martelli A
Pharmacol Res; 2009 Jul; 60(1):1-17. PubMed ID: 19427580
[TBL] [Abstract][Full Text] [Related]
7. Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals.
Brambilla G; Martelli A
Mutat Res; 2009; 681(2-3):209-229. PubMed ID: 18845271
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
Kirkland D; Aardema M; Müller L; Makoto H
Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
10. Studies on genotoxicity and carcinogenicity of antibacterial, antiviral, antimalarial and antifungal drugs.
Brambilla G; Mattioli F; Robbiano L; Martelli A
Mutagenesis; 2012 Jul; 27(4):387-413. PubMed ID: 22228823
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity and carcinogenicity studies of benzodiazepines.
Brambilla G; Carrozzino R; Martelli A
Pharmacol Res; 2007 Dec; 56(6):443-58. PubMed ID: 17920927
[TBL] [Abstract][Full Text] [Related]
12. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
Kirkland D; Reeve L; Gatehouse D; Vanparys P
Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
[TBL] [Abstract][Full Text] [Related]
13. Genotoxicity and carcinogenicity studies of antihistamines.
Brambilla G; Mattioli F; Robbiano L; Martelli A
Arch Toxicol; 2011 Oct; 85(10):1173-87. PubMed ID: 21327970
[TBL] [Abstract][Full Text] [Related]
14. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
[TBL] [Abstract][Full Text] [Related]
15. Genotoxic and carcinogenic effects of antipsychotics and antidepressants.
Brambilla G; Mattioli F; Martelli A
Toxicology; 2009 Jul; 261(3):77-88. PubMed ID: 19410629
[TBL] [Abstract][Full Text] [Related]
16. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
Battershill JM; Fielder RJ
Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
[TBL] [Abstract][Full Text] [Related]
17. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
[TBL] [Abstract][Full Text] [Related]
18. Analysis of published data for top concentration considerations in mammalian cell genotoxicity testing.
Parry JM; Parry E; Phrakonkham P; Corvi R
Mutagenesis; 2010 Nov; 25(6):531-8. PubMed ID: 20720196
[TBL] [Abstract][Full Text] [Related]
19. Genotoxicity testing: current practices and strategies used by the pharmaceutical industry.
Purves D; Harvey C; Tweats D; Lumley CE
Mutagenesis; 1995 Jul; 10(4):297-312. PubMed ID: 7476265
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
